In the News

Share

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
COVID-19: Information for Patients and Caregivers

We're here for you, and continue to provide cancer care to new and current patients. Learn about our response to COVID-19.

What you need to know

1731 News Items found
Detail shot of a scientist purifying proteins
MSK Research Highlights, July 31, 2024

New MSK research showed giving chemotherapy shortly after a stem cell or bone marrow transplant from a less than perfectly matched donor greatly reduces the chances that the patient will develop graft-versus-host disease (GVHD); and sheds new light on cell state changes in prostate cancer.
Grace Yang reclines in a hospital bed and holds a bag of stem cells.
Donating Bone Marrow and Stem Cells: The Process and What To Expect

Learn everything you need to know about donating bone marrow or blood stem cells and why it’s important to join a public registry.
Dr. Jun Mao performs acupuncture
Acupuncture for Neuropathy, Cancer Pain, Anxiety, and More

Learn about the latest research on acupuncture from MSK and how our investigators are studying the benefits of acupuncture for relieving the side effects of cancer and its therapies.
MSK exercise scientist Lee Jones, PhD, is seen in a gym.
Can Exercise Impact Prostate Cancer? A First of its Kind Clinical Trial

Learn how exercise may affect the treatment of prostate cancer, in a first of its kind clinical trial at Memorial Sloan Kettering Cancer Center.
Andrea Schietinger
Better Together: Spatial Arrangement of Three Immune Cells Is Key to Attacking Tumors

In order for immune cells to effectively kill cancer cells, a triad of three cells are necessary — a dendritic cell, a cytotoxic “killer” T cell, and a helper T cell, researchers at MSK and Baylor College of Medicine have found. The discovery could alter the way doctors administer immunotherapies.
Ellen Horste
From Basic Science to Biotech: One MSK Alum’s Journey

Learn how GSK graduate Dr. Ellen Horste’s time investigating fundamental biological questions prepared her for a career in the emerging field of gene therapy.
Family of four sitting and smiling for camera.
Metastatic Breast Cancer and Motherhood: Staying Hopeful

Learn how MSK's expertise in metastatic breast cancer helped a mother celebrate a long-awaited milestone with her family.
Ask the Expert
Mammogram being given by radiology technician to patient.
Dense Breast Tissue and Cancer Risk: What You Should Know

Learn about dense breast tissue and what it means for your cancer risk and screening needs.
Pancreatic cancer cells
MSK Discovery Suggests Opportunity to Improve Effectiveness of KRAS Inhibitors Against Pancreatic Cancer

MSK researchers have discovered a new mechanism of resistance to KRAS inhibitors that suggests an opportunity to make the treatment more effective.
Giovanna Whitting
For Thyroid Cancers with RET Mutations, FDA Approves Selpercatinib

The FDA has granted full approval to the targeted therapy selpercatinib (Retevmo®) for treating thyroid cancers that have certain changes in a gene called RET. Learn about MSK’s role in the development of this drug and about how patients may benefit.